Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Gastrointestinal Endoscopy
|
March 23, 2010
Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer Research (SAKK 75/02)
Christian Jost, Janek Binek, Jan C Schuller, et al.
Leukemia & Lymphoma
|
April 4, 2013
Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07)
Jakob R Passweg, Thomas Pabst, Sabine Blum, et al.
Endocrine Connections
|
August 18, 2017
Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients
Martin Zweifel, Beat Thürlimann, Salome Riniker, et al.
International Journal of Colorectal Disease
|
October 8, 2016
Prospective multicenter registration study of colorectal cancer: significant variations in radicality and oncosurgical quality-Swiss Group for Clinical Cancer Research Protocol SAKK 40/00
Christoph A Maurer, Daniel Dietrich, Martin K Schilling, et al.
Radiation Oncology (London, England)
|
January 15, 2017
External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26
Evelyn Herrmann, Diana Naehrig, Manfred Sassowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2011
Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06)
Thomas Ruhstaller, Miklos Pless, Daniel Dietrich, et al.
Swiss Medical Weekly
|
October 16, 2025
Accelerating innovation: implementation science as a cornerstone of high-performance Swiss research infrastructures
Sabina M De Geest, Christina Akre, Carole E Aubert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2002
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer
Markus M Borner, Daniel Dietrich, Roger Stupp, et al.
Onkologie
|
December 18, 2009
Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02)
Bernd Klaeser, Egbert Nitzsche, Jan C Schuller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 15, 2012
Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07)
Richard Cathomas, Christian Rothermundt, Dirk Klingbiel, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Gastrointestinal Endoscopy
|
March 23, 2010
Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer Research (SAKK 75/02)
Christian Jost, Janek Binek, Jan C Schuller, et al.
Leukemia & Lymphoma
|
April 4, 2013
Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07)
Jakob R Passweg, Thomas Pabst, Sabine Blum, et al.
Endocrine Connections
|
August 18, 2017
Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients
Martin Zweifel, Beat Thürlimann, Salome Riniker, et al.
International Journal of Colorectal Disease
|
October 8, 2016
Prospective multicenter registration study of colorectal cancer: significant variations in radicality and oncosurgical quality-Swiss Group for Clinical Cancer Research Protocol SAKK 40/00
Christoph A Maurer, Daniel Dietrich, Martin K Schilling, et al.
Radiation Oncology (London, England)
|
January 15, 2017
External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26
Evelyn Herrmann, Diana Naehrig, Manfred Sassowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2011
Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06)
Thomas Ruhstaller, Miklos Pless, Daniel Dietrich, et al.
Swiss Medical Weekly
|
October 16, 2025
Accelerating innovation: implementation science as a cornerstone of high-performance Swiss research infrastructures
Sabina M De Geest, Christina Akre, Carole E Aubert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2002
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer
Markus M Borner, Daniel Dietrich, Roger Stupp, et al.
Onkologie
|
December 18, 2009
Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02)
Bernd Klaeser, Egbert Nitzsche, Jan C Schuller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 15, 2012
Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07)
Richard Cathomas, Christian Rothermundt, Dirk Klingbiel, et al.
Page
of 3